RELAY THERAPEUTICS INC (RLAY) Stock Earnings & Estimates
USA - NASDAQ:RLAY - US75943R1023 - Common Stock
6.05 USD
-0.48 (-7.35%)
6.01 USD
-0.04 (-0.66%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.38M -54.46% | 25.546M 1,751.16% | 10.007M -60.83% | 12.739M 27.30% | 13.685M 7.43% | 31.653M 131.30% | 9.156M -71.07% | 102.67M 1,021.34% | 301.36M 193.52% | 618.01M 105.07% | 887.79M 43.65% | |
| EBITDA YoY % growth | -295.15M 15.41% | -367.731M -24.59% | -367.004M 0.20% | -319.12M 13.05% | -327.759M -2.71% | -321.3M 1.97% | -293.168M 8.76% | -132.07M 54.95% | 75.398M 157.09% | 232.1M 207.83% | 367.43M 58.31% | |
| EBIT YoY % growth | -299.28M 15.18% | -373M -24.63% | -372.468M 0.14% | -320.366M 13.99% | -333.199M -4.01% | -356.64M -7.03% | -350.44M 1.74% | -318.219M 9.19% | -180.676M 43.22% | 101.79M 156.34% | 293.78M 188.61% | |
| Operating Margin | -21,686.96% | -1,460.11% | -3,722.07% | -2,514.84% | -2,434.78% | -1,126.72% | -3,827.43% | -309.94% | -59.95% | 16.47% | 33.09% | |
| EPS YoY % growth | -2.60 32.47% | -2.80 -7.69% | -2.39 14.64% | -1.73 27.56% | -1.75 -0.93% | -1.99 -14.06% | -1.68 15.90% | -1.43 14.81% | -0.92 35.48% | 0.13 113.84% | 0.97 664.00% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.39 12.84% | -0.41 10.71% | -0.41 -0.51% | -0.38 10.93% | -0.35 9.50% | -0.38 8.11% | -0.38 8.42% | -0.37 4.13% | -0.30 16.67% |
| Revenue Q2Q % growth | 6.512M | 33.997K -99.56% | 33.997K -94.98% | 204K | 8.007M 22.96% | 81.6K 140.02% | 81.6K 140.02% | 81.6K -60.00% | 15.382M 92.11% |
| EBITDA Q2Q % growth | -73.78M 7.21% | -71.033M 15.09% | -72.42M 2.97% | -72.42M 6.16% | -58.14M 21.20% | -74.46M -4.82% | -75.48M -4.23% | -76.5M -5.63% | -62.22M -7.02% |
| EBIT Q2Q % growth | -73.505M 13.50% | -78.976M 6.94% | -81.181M -5.64% | -69.967M 11.85% | -61.766M 15.97% | -75.674M 4.18% | -76.439M 5.84% | -77.204M -10.34% | -62.679M -1.48% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -0.43 31.75% | -0.42 | -0.01 | -1.47% |
| Q2 2025 Q2Q % growth | -0.41 40.58% | -0.50 | 0.09 | 18.23% |
| Q1 2025 Q2Q % growth | -0.46 25.81% | -0.50 | 0.04 | 7.59% |
| Q4 2024 Q2Q % growth | -0.45 32.84% | -0.57 | 0.12 | 21.46% |
| Q3 2024 Q2Q % growth | -0.63 -16.67% | -0.78 | 0.15 | 19.53% |
| Q2 2024 Q2Q % growth | -0.69 14.81% | -0.75 | 0.06 | 7.69% |
| Q1 2024 Q2Q % growth | -0.62 20.51% | -0.72 | 0.10 | 13.77% |
| Q4 2023 Q2Q % growth | -0.67 -19.64% | -0.74 | 0.07 | 9.82% |
| Q3 2023 Q2Q % growth | -0.54 28.95% | -0.85 | 0.31 | 36.27% |
| Q2 2023 Q2Q % growth | -0.81 -14.08% | -0.83 | 0.02 | 2.64% |
| Q1 2023 Q2Q % growth | -0.78 -36.84% | -0.71 | -0.07 | -10.62% |
| Q4 2022 Q2Q % growth | -0.56 9.68% | -0.72 | 0.16 | 21.82% |
| Q3 2022 Q2Q % growth | -0.76 -15.15% | -0.72 | -0.04 | -5.60% |
| Q2 2022 Q2Q % growth | -0.71 66.19% | -0.64 | -0.07 | -10.74% |
| Q1 2022 Q2Q % growth | -0.57 -21.28% | -0.63 | 0.06 | 9.62% |
| Q4 2021 Q2Q % growth | -0.62 -188.57% | -0.59 | -0.03 | -5.10% |
| Q3 2021 Q2Q % growth | -0.66 -29.41% | -0.65 | -0.01 | -1.33% |
| Q2 2021 Q2Q % growth | -2.10 65.35% | -0.46 | -1.64 | -351.78% |
| Q1 2021 Q2Q % growth | -0.47 | -0.49 | 0.02 | 4.99% |
| Q4 2020 Q2Q % growth | 0.70 | 0.17 | 0.53 | 307.70% |
| Q3 2020 Q2Q % growth | -0.51 | -0.35 | -0.16 | -44.51% |
| Q2 2020 Q2Q % growth | -6.06 | -0.68 | -5.38 | -796.78% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 186.517K | -186.517K | -100.00% | |
| Q2 2025 Q2Q % growth | 677K | 61.2K | 615.8K | 1,006.21% |
| Q1 2025 Q2Q % growth | 7.679M -23.26% | 10.2K | 7.669M | 75,184.31% |
| Q4 2024 Q2Q % growth | 6.202M | -6.202M | -100.00% | |
| Q3 2024 Q2Q % growth | -100.00% | 81.6K | -81.6K | -100.00% |
| Q2 2024 Q2Q % growth | -100.00% | 81.6K | -81.6K | -100.00% |
| Q1 2024 Q2Q % growth | 10.007M 4,327.88% | 79.336K | 9.928M | 12,513.51% |
| Q4 2023 Q2Q % growth | 25.546M -100.00% | 129.815K | -129.815K | -100.00% |
| Q3 2023 Q2Q % growth | 25.202M 7,312.35% | 375.697K | 24.826M | 6,608.07% |
| Q2 2023 Q2Q % growth | 119K -67.84% | 706.86K | -587.86K | -83.16% |
| Q1 2023 Q2Q % growth | 226K -46.19% | 191.76K | 34.24K | 17.86% |
| Q4 2022 Q2Q % growth | 250K -56.14% | 3.366M | -3.116M | -92.57% |
| Q3 2022 Q2Q % growth | 340K -49.25% | 1.689M | -1.349M | -79.87% |
| Q2 2022 Q2Q % growth | 370K -55.95% | 1.967M | -1.597M | -81.19% |
| Q1 2022 Q2Q % growth | 420K -55.79% | 170.003K | 249.997K | 147.05% |
| Q4 2021 Q2Q % growth | 570K -99.31% | 3.917M | -3.347M | -85.45% |
| Q3 2021 Q2Q % growth | 670K | 109.283K | 560.717K | 513.09% |
| Q2 2021 Q2Q % growth | 840K | 6.8M | -5.96M | -87.65% |
| Q1 2021 Q2Q % growth | 950K | 4.151M | -3.201M | -77.11% |
| Q4 2020 Q2Q % growth | 82.65M | 37.4M | 45.25M | 120.99% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 1.51% | 12.52% | 1.01% | 9.13% |
| Revenue | 0% | 265.72% | -0.02% | 8.26% |